Literature DB >> 28223321

A non-canonical function of Ezh2 preserves immune homeostasis.

Ajithkumar Vasanthakumar1,2, Dakang Xu3,4,5, Aaron Tl Lun1,2, Andrew J Kueh1,2, Klaas Pjm van Gisbergen1,2, Nadia Iannarella1, Xiaofang Li3,4,5, Liang Yu4,5, Die Wang4,5, Bryan Rg Williams4,5, Stanley Cw Lee1,2, Ian J Majewski1,2, Dale I Godfrey6,7, Gordon K Smyth1,8, Warren S Alexander1,2, Marco J Herold1,2, Axel Kallies1,2, Stephen L Nutt9,2, Rhys S Allan9,2.   

Abstract

Enhancer of zeste 2 (Ezh2) mainly methylates lysine 27 of histone-H3 (H3K27me3) as part of the polycomb repressive complex 2 (PRC2) together with Suz12 and Eed. However, Ezh2 can also modify non-histone substrates, although it is unclear whether this mechanism has a role during development. Here, we present evidence for a chromatin-independent role of Ezh2 during T-cell development and immune homeostasis. T-cell-specific depletion of Ezh2 induces a pronounced expansion of natural killer T (NKT) cells, although Ezh2-deficient T cells maintain normal levels of H3K27me3. In contrast, removal of Suz12 or Eed destabilizes canonical PRC2 function and ablates NKT cell development completely. We further show that Ezh2 directly methylates the NKT cell lineage defining transcription factor PLZF, leading to its ubiquitination and subsequent degradation. Sustained PLZF expression in Ezh2-deficient mice is associated with the expansion of a subset of NKT cells that cause immune perturbation. Taken together, we have identified a chromatin-independent function of Ezh2 that impacts on the development of the immune system.
© 2017 The Authors.

Entities:  

Keywords:  Ezh2; chromatin; lymphocyte; methylation; polycomb

Mesh:

Substances:

Year:  2017        PMID: 28223321      PMCID: PMC5376973          DOI: 10.15252/embr.201643237

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  52 in total

1.  A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.

Authors:  P P Lee; D R Fitzpatrick; C Beard; H K Jessup; S Lehar; K W Makar; M Pérez-Melgosa; M T Sweetser; M S Schlissel; S Nguyen; S R Cherry; J H Tsai; S M Tucker; W M Weaver; A Kelso; R Jaenisch; C B Wilson
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

Review 2.  Histone acetyltransferases.

Authors:  S Y Roth; J M Denu; C D Allis
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

3.  Role of histone H3 lysine 27 methylation in Polycomb-group silencing.

Authors:  Ru Cao; Liangjun Wang; Hengbin Wang; Li Xia; Hediye Erdjument-Bromage; Paul Tempst; Richard S Jones; Yi Zhang
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728

4.  T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells.

Authors:  Michael J Townsend; Amy S Weinmann; Jennifer L Matsuda; Rachelle Salomon; Peggy J Farnham; Christine A Biron; Laurent Gapin; Laurie H Glimcher
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

5.  The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells.

Authors:  Luana O Atherly; Julie A Lucas; Martin Felices; Catherine C Yin; Steven L Reiner; Leslie J Berg
Journal:  Immunity       Date:  2006-07       Impact factor: 31.745

Review 6.  The biology of NKT cells.

Authors:  Albert Bendelac; Paul B Savage; Luc Teyton
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 7.  A role for natural killer T cells in asthma.

Authors:  Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Nat Rev Immunol       Date:  2006-10-27       Impact factor: 53.106

8.  Polycomb group protein ezh2 controls actin polymerization and cell signaling.

Authors:  I-hsin Su; Marc-Werner Dobenecker; Ephraim Dickinson; Matthew Oser; Ashwin Basavaraj; Raphael Marqueron; Agnes Viale; Danny Reinberg; Christoph Wülfing; Alexander Tarakhovsky
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

9.  Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.

Authors:  I-Hsin Su; Ashwin Basavaraj; Andrew N Krutchinsky; Oliver Hobert; Axel Ullrich; Brian T Chait; Alexander Tarakhovsky
Journal:  Nat Immunol       Date:  2002-12-23       Impact factor: 25.606

10.  CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.

Authors:  K H Sonoda; M Exley; S Snapper; S P Balk; J Stein-Streilein
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  33 in total

1.  Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease.

Authors:  Wan Song; Nóra Zsindely; Anikó Faragó; J Lawrence Marsh; László Bodai
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

2.  Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer.

Authors:  Yunfeng Bai; Zhuangzhuang Zhang; Lijun Cheng; Ruixin Wang; Xiaoliang Chen; Yifan Kong; Feng Feng; Nihal Ahmad; Lang Li; Xiaoqi Liu
Journal:  J Biol Chem       Date:  2019-05-13       Impact factor: 5.157

3.  Polycomb repressive complex 2 is a critical mediator of allergic inflammation.

Authors:  Christine R Keenan; Nadia Iannarella; Alexandra L Garnham; Alexandra C Brown; Richard Y Kim; Jay C Horvat; Philip M Hansbro; Stephen L Nutt; Rhys S Allan
Journal:  JCI Insight       Date:  2019-05-16

Review 4.  The Unexpected Noncatalytic Roles of Histone Modifiers in Development and Disease.

Authors:  Yann Aubert; Shaun Egolf; Brian C Capell
Journal:  Trends Genet       Date:  2019-07-10       Impact factor: 11.639

5.  Progranulin regulates the development and function of NKT2 cells through EZH2 and PLZF.

Authors:  Zuochen Du; Lu Huang; Xin Dai; Di Yang; Linlin Niu; Heather Miller; Changshun Ruan; Han Li; Leling Hu; Lijia Zhou; Ding Jian; Jian Sun; Xiaoqi Shi; Pei Huang; Yan Chen; Xiaodong Zhao; Chaohong Liu
Journal:  Cell Death Differ       Date:  2022-04-21       Impact factor: 12.067

Review 6.  EZH2-Targeted Therapies in Cancer: Hype or a Reality.

Authors:  Marie-Lisa Eich; James E Ferguson; Sooryanarayana Varambally; Mohammad Athar
Journal:  Cancer Res       Date:  2020-09-25       Impact factor: 12.701

7.  The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2.

Authors:  Mónica Ferreira; Iris Verbinnen; Margarida Fardilha; Aleyde Van Eynde; Mathieu Bollen
Journal:  J Biol Chem       Date:  2018-10-10       Impact factor: 5.157

Review 8.  Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer.

Authors:  Talha Anwar; Maria E Gonzalez; Celina G Kleer
Journal:  Am J Pathol       Date:  2021-02-06       Impact factor: 4.307

Review 9.  Lineage Differentiation Program of Invariant Natural Killer T Cells.

Authors:  Dong-Il Kwon; You Jeong Lee
Journal:  Immune Netw       Date:  2017-11-27       Impact factor: 6.303

10.  Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activity.

Authors:  Myriam Koubi; Mathilde Poplineau; Julien Vernerey; Lia N'Guyen; Guillaume Tiberi; Sylvain Garciaz; Abdessamad El-Kaoutari; Muhammad A Maqbool; Jean-Christophe Andrau; Christel Guillouf; Andrew J Saurin; Estelle Duprez
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.